Why Nanosphere (NSPH) Stock Is Surging Today

NEW YORK (TheStreet) -- Nanosphere  (NSPH) surged Wednesday after the molecular diagnostics company announced it has received FDA clearance for the bacterial portion of its Verigene Enteric Pathogens Nucleic Acid Test.

The company has completed clinical studies for the entire panel, including two more viral targets, and expects clearance of the full EP panel.

The stock was up 14.8% to $1.63 at 2:10 p.m. More than 6.1 million shares had changed hands, compared to the average volume of 833,709.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

NSPH Price Chart

NSPH Price data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

Insider Trading Alert - NSPH, SIGI And CFFI Traded By Insiders

Insider Trading Alert - NSP, CTXS And NSPH Traded By Insiders

Nanosphere (NSPH) Stock Surging as Luminex Ups Bid

Nanosphere (NSPH) Stock Skyrockets on $58 Million Luminex Deal

4 Stocks Under $10 Making Big Moves Higher